MAPK3 and renal cell carcinoma: Importantly, using small molecules of Ca2+ influx (verapamil) or p-ERK1/2(SCH772984) to suppress the ATP-P2RX6-Ca2+ −p-ERK1/2 signaling all led to suppress the RCC progression and metastasis (Fig. 6c).